F. Fortune

发表

The influence of oral health and psycho-social well-being on clinical outcomes in Behçet’s disease

A. Senusi, S. Higgins, F. Fortune, 2018, Rheumatology International.

Quantitative optical coherence tomography of fluid-filled oral mucosal lesions

D. Bader, F. Fortune, P. Tomlins, 2013, Lasers in Medical Science.

A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.

F. Liu, M. Teh, F. Fortune, 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Downstream Targets of FOXM 1 : CEP 55 and HELLS are Cancer Progression Markers of Head and Neck Squamous Cell Carcinoma

M. Teh, F. Fortune, A. Waseem, 2011 .

Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.

M. Teh, F. Fortune, A. Waseem, 2010, Oral oncology.

Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus Vulgaris

E. K. Parkinson, F. Fortune, Yang Cai, 2021, Frontiers in Immunology.

Behçet’s Disease: Do Natural Killer Cells Play a Significant Role?

F. Fortune, M. Stanford, G. Wallace, 2015, Front. Immunol..

Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease.

T. Ahmad, D. Jewell, S. Marshall, 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease

J. Sanderson, T. Lehner, F. Fortune, 1996, The Lancet.

Clinical Review: Familial Mediterranean Fever—An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment

F. Fortune, M. Stanford, A. Jawad, 2016, Ocular immunology and inflammation.

FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant Transformation

S. Teo, S. Cheong, D. Sugden, 2009, PloS one.

Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations

R. Moots, I. Olivieri, P. Sfikakis, 2018, Rheumatology.

Renal disease and the mouth.

F. Fortune, N. Ashman, W. Tilakaratne, 2007, The American journal of medicine.

Organ‐specific management and supportive care in chronic graft‐versus‐host disease

J. Scarisbrick, F. Fortune, F. Dignan, 2012, British journal of haematology.

BCSH/BSBMT Guideline: Organ-Specific Management and Supportive Care in Chronic Graft-versus -Host Disease

F. Fortune, A. Clark, G. Jackson, 2012 .

Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behçet's disease

F. Fortune, A. Lalli, O. Kose, 2007, Clinical and experimental dermatology.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

R. Moots, I. Olivieri, P. Sfikakis, 2019, Seminars in arthritis and rheumatism.

T‐cell epitopes recognized within the 65 000 MW hsp in patients‘qc with IgA nephropathy

T. Lehner, F. Fortune, T. Shinnick, 1997, Immunology.

Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function

H. L. Wright, R. Moots, T. Spector, 2012 .

New mouthwash: an efficacious intervention for oral ulceration associated with Behçet's disease.

Angray S. Kang, A. Senusi, F. Fortune, 2020, The British journal of oral & maxillofacial surgery.

Genital ulcer severity score and genital health quality of life in Behçet’s disease

L. Bergmeier, A. Senusi, F. Fortune, 2015, Orphanet Journal of Rare Diseases.

Behçet's syndrome and health-related quality of life: influence of symptoms, lifestyle and employment status.

A. Senusi, F. Fortune, Dennis Ola, 2017, Clinical and experimental rheumatology.

Behçet's disease – a delay in diagnosis: why look in the mouth?

F. Fortune, A. Dalghous, J. O. Elkhabuli, 2009 .

RNAi‐mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation

F. Fortune, H. Wan, T. Mannan, 2011, Cell proliferation.

Desmoglein 3, via an Interaction with E-cadherin, Is Associated with Activation of Src

M. Teh, F. Fortune, A. Wheeler, 2010, PloS one.

A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD.

R. Dwek, T. Lehner, R. Parekh, 1994, Immunology.

Lectin-Carbohydrate Interactions in Disease

R. Dwek, T. Lehner, R. Parekh, 1995 .

Lectin-carbohydrate interactions in disease. T-cell recognition of IgA and IgD; mannose binding protein recognition of IgG0.

R. Dwek, T. Lehner, R. Parekh, 1995, Advances in experimental medicine and biology.

Oral cancer screening in the Bangladeshi community of Tower Hamlets: a social model

F. Fortune, R. Croucher, A. Lalli, 2009, British Journal of Cancer.

Non-infectious Diseases of the Oral Mucosa: The Importance of Immune Functions

L. Bergmeier, F. Fortune, 2018 .

Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.

F. Fortune, P. Dandona, R. Greenbaum, 1985, British heart journal.

Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.

M. Macey, F. Fortune, P. Shirlaw, 2011, Rheumatology.

Differential Expression of Suppressor of Cytokine Signalling Proteins in Behçet's Disease

L. Bergmeier, F. Fortune, S. Vartoukian, 2014, Scandinavian journal of immunology.

T and B cell responses following immunization with tetanus toxoid in IgA nephropathy

T. Lehner, F. Fortune, M. Courteau, 1992, Clinical and experimental immunology.

Type 2 diabetes risk screening in dental practice settings: a pilot study

F. Fortune, V. Muirhead, S. Weston-Price, 2014, BDJ.

Senescent mesenchymal cells accumulate in human fibrosis by a telomere‐independent mechanism and ameliorate fibrosis through matrix metalloproteinases

E. K. Parkinson, F. Fortune, P. Slijepcevic, 2011, The Journal of pathology.

Oral health and impact on performance of athletes participating in the London 2012 Olympic Games: a cross-sectional study

L. Engebretsen, A. Petrie, F. Fortune, 2013, British Journal of Sports Medicine.

Recognition of B‐Cell Epitopes of the 65 kDa HSP in Behçet's Disease

T. Lehner, F. Fortune, T. Shinnick, 1996, Scandinavian journal of immunology.

CTLA-4 polymorphisms are not associated with ocular inflammatory disease.

R. Vaughan, E. Ben-Chetrit, P. Murray, 2008, Tissue antigens.

Genital and Oral Microbiome and Behçet’s Disease Activity

A. Senusi, F. Fortune, A. Sandionigi, 2022 .

Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.

E. K. Parkinson, M. Teh, A. Ariyawardana, 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Upregulation of HIF-1a in malignant transformation of oral submucous fibrosis

E. K. Parkinson, M. Teh, A. Ariyawardana, 2008 .

The Assessment of Presenteeism and Activity Impairment in Behcet's Syndrome and Recurrent Aphthous Stomatitis: A multicentre Study.

U. Karaçayli, T. Ergun, F. Fortune, 2021, Rheumatology.

Chemokine gene polymorphisms associate with gender in patients with uveitis.

R. Vaughan, F. Fortune, M. Stanford, 2004, Tissue antigens.

Mental Disorders and Oral Diseases: Future Research Directions

F. Fortune, R. Watt, S. Kisely, 2022, Journal of dental research.

Role of γδ T cells in Behcet's disease

T. Lehner, F. Fortune, Amanda Wilson, 1996, The Lancet.

The role of TLR2 and 4 in Behçet's disease pathogenesis

L. Bergmeier, F. Fortune, M. Curtis, 2014, Innate immunity.

Glucocorticoid sensitivity in Behçet's disease

E. Ben-Chetrit, S. Lamberts, F. Fortune, 2012, Endocrine connections.

Circulating NK cells and their subsets in Behçet's disease

L. Bergmeier, F. Fortune, P. Ryan, 2017, Clinical and experimental immunology.

Identification and characterization of IgA and Vicia villosa‐binding T cell subsets in rheumatoid arthritis

T. Lehner, F. Fortune, J. Kingston, 1990, Clinical and experimental immunology.

Identification andcharacterization ofIgAandViciavillosa-binding T cell subsets inrheumatoid arthritis

T. Lehner, F. Fortune, J. Kingston, 1990 .

KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease

P. Parham, F. Fortune, P. Norman, 2019, The Journal of Immunology.

2018 update of the EULAR recommendations for the management of Behçet’s syndrome

R. Moots, I. Olivieri, P. Sfikakis, 2018, Annals of the rheumatic diseases.

Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet’s disease

R. Vaughan, F. Fortune, M. Stanford, 2003, The British journal of ophthalmology.

Phenotypic expression of Vicia villosa binding T cell subsets, as markers of contrasuppressor cells in systemic lupus erythematosus.

T. Lehner, F. Fortune, 1988, Clinical and experimental immunology.

Dysregulation of the suppressor of cytokine signalling 3–signal transducer and activator of transcription‐3 pathway in the aetiopathogenesis of Sjögren's syndrome

L. Bergmeier, F. Fortune, S. Vartoukian, 2014, Clinical and experimental immunology.

TIRAP Ser180Leu polymorphism is associated with Behcet's disease.

R. Vaughan, E. Ben-Chetrit, P. Murray, 2011, Rheumatology.

Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing.

E. K. Parkinson, M. Teh, F. Fortune, 2012, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Can you catch Behçet's disease?

F. Fortune, 2003, The Journal of laboratory and clinical medicine.

Oral Biopsies from Patients with Orofacial Granulomatosis with Histology Resembling Crohn's Disease Have a Prominent Th1 Environment

F. Fortune, W. Tilakaratne, J. Freysdottir, 2007, Inflammatory bowel diseases.

IL-10 genotype analysis in patients with Behçet's disease.

R. Vaughan, F. Fortune, M. Stanford, 2007, Human immunology.

Induction of p53 in keratinocyte cultures treated with Behçet's patient sera.

Angray S. Kang, E. K. Parkinson, F. Fortune, 2020, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

The Expression of Carbohydrate Antigens in Activated T Cells and in Autoimmune Diseases

T. Lehner, F. Fortune, J. Walker, 1994, Scandinavian journal of immunology.

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R/IL12RB2 regions associated with Behçet's disease

Christopher I. Amos, Aris Cakiris, Massimo Gadina, 2010, Nature Genetics.

Fluoride incorporation in high phosphate containing bioactive glasses and in vitro osteogenic, angiogenic and antibacterial effects.

F. Fortune, S. Rawlinson, R. Hill, 2016, Dental materials : official publication of the Academy of Dental Materials.

Strontium-substituted bioactive glasses in vitro osteogenic and antibacterial effects.

F. Fortune, S. Rawlinson, R. Hill, 2016, Dental materials : official publication of the Academy of Dental Materials.

Betel‐derived alkaloid up‐regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis

P. Weinreb, S. Violette, G. Thomas, 2011, The Journal of pathology.

Non‐junctional human desmoglein 3 acts as an upstream regulator of Src in E‐cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris

F. Fortune, R. Grose, I. Hart, 2012, The Journal of pathology.

Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease.

T. Lehner, F. Fortune, T. Shinnick, 1996, Lancet.

Orofacial granulomatosis: review on aetiology and pathogenesis.

F. Fortune, W. Tilakaratne, J. Freysdottir, 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

The oral mucosal and salivary microbial community of Behçet's syndrome and recurrent aphthous stomatitis

L. Bergmeier, F. Drobniewski, B. Paster, 2015, Journal of oral microbiology.

A systematic review of medical interventions for oral submucous fibrosis and future research opportunities.

A. Mighell, M. Nasser, F. Fortune, 2011, Oral diseases.

Improving morbidity and mortality in peripheral ulcerative keratitis associated with rheumatoid arthritis.

F. Fortune, M. Stanford, A. Jawad, 2016, Clinical and experimental rheumatology.

Why are Behçet's disease patients always exhausted?

L. Bergmeier, D. Kidd, A. Senusi, 2018, Clinical and experimental rheumatology.

Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet’s Disease

L. Bergmeier, F. Fortune, T. Novak, 2021, Frontiers in Immunology.

Oral Health and Its Aetiological Role in Behçet's Disease

F. Fortune, G. Mumcu, 2021, Frontiers in Medicine.

Behçet Syndrome and Microbes

F. Fortune, G. Hatemi, 2019, Behçet Syndrome.

Human Disease for Dentistry

F. Fortune, 2004 .

An altered keratinocyte phenotype in oral submucous fibrosis: correlation of keratin K17 expression with disease severity.

E. K. Parkinson, I. Leigh, M. Teh, 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?

T. Ahmad, D. Jewell, S. Marshall, 2003, Arthritis and rheumatism.

Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?

P. Murray, F. Fortune, M. Stanford, 2008, Immunology letters.

Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1‐associated, although Th2‐association is also observed in patients with BD

F. Fortune, J. Freysdottir, A. Dalghous, 2006, Scandinavian journal of rheumatology.

Neutrophil elastase and endogenous inhibitors in Behçet’s disease saliva

L. Bergmeier, F. Fortune, T. Novak, 2020, Clinical and experimental immunology.

Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.

F. Fortune, S. Lau, J. Freysdottir, 2006, Oral diseases.

CARD15 polymorphisms in Behçet's disease

T. Ahmad, D. Jewell, S. Marshall, 2005, Scandinavian Journal of Rheumatology.

The seroprevalence and salivary shedding of herpesviruses in Behçet's syndrome and recurrent aphthous stomatitis

L. Bergmeier, F. Fortune, E. Hagi-Pavli, 2015, Journal of oral microbiology.

Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease

L. Bergmeier, F. Fortune, H. Petrushkin, 2015, Journal of immunology research.

Impact of Behçet's syndrome on health-related quality of life: influence of the type and number of symptoms.

E. Bernabé, W. Marcenes, F. Fortune, 2010, Rheumatology.

Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease.

T. Ergun, F. Fortune, G. Mumcu, 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Behçet's syndrome in children and young people in the United Kingdom & Republic of Ireland: a prospective epidemiological study.

R. Moots, D. Taylor-Robinson, F. Fortune, 2021, Rheumatology.

The association of the PTPN22 620W polymorphism with Behçet’s disease

R. Vaughan, P. Murray, F. Fortune, 2007, Annals of the rheumatic diseases.

Atypical palatal ulceration.

F. Fortune, L. Churchill, A. S. Hasan, 1995, Postgraduate medical journal.

Brown tumours: widespread involvement of multiple maxillofacial bones and cervical spine

F. Fortune, O. Adegun, T. Gadhia, 2014, BMJ Case Reports.

Fingerprinting genomic instability in oral submucous fibrosis.

M. Teh, A. Ariyawardana, F. Fortune, 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

The dental team as part of the medical workforce during national and global crises

F. Fortune, S. Chana, S. Sacoor, 2020, British Dental Journal.

Genome-wide association study identifies variants in the MHC class I , IL 10 , and IL 23 R / IL 12 RB 2 regions associated with Behçet ' s disease

C. Amos, W. Chen, E. Remmers, 2016 .

Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.

I. Mackenzie, F. Fortune, J. Common, 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Adamantiades‐Behçet's disease (Behçet's disease) and COVID‐19

F. Shahram, P. Sfikakis, F. Fortune, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics

F. Fortune, A. Wheeler, Luke Gammon, 2012, Experimental cell research.

A cross-sectional study on activity impairment in primary Sjogren's syndrome.

F. Fortune, G. Mumcu, N. Inanç, 2023, Oral diseases.

Quantitative analysis of optical coherence tomography and histopathology images of normal and dysplastic oral mucosal tissues

Dan L. Bader, D. Bader, F. Fortune, 2012, Lasers in Medical Science.

Remote telephone clinics in oral medicine: reflections on the place of virtual clinics in a specialty that relies so heavily on visual assessment. A note of caution.

F. Fortune, J. Buchanan, J. Macken, 2020, The British journal of oral & maxillofacial surgery.

Scattering attenuation microscopy of oral epithelial dysplasia.

D. Bader, F. Fortune, P. Tomlins, 2010, Journal of biomedical optics.

Expression of adhesion and activation molecules in human buccal epithelial cell lines and normal human buccal epithelium in situ.

F. Fortune, J. Freysdottir, A. Dalghous, 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Behçet's patients' response to COVID-19 vaccination.

A. Senusi, F. Fortune, C. Pade, 2023, Clinical immunology.

Profiling the microbiome of oral and genital mucosal surfaces in Behçet's disease.

A. Senusi, F. Fortune, A. Sandionigi, 2023, Clinical immunology.

Low prevalence of NOD2 SNPs in Behçet's disease suggests protective association in Caucasians.

F. Rivadeneira, L. Stolk, R. Kuijpers, 2009, Rheumatology.

γδ T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS)

F. Fortune, J. Freysdottir, Fortune, 1999, Clinical and experimental immunology.

The impact of multifactorial factors on the Quality of Life of Behçet's patients over 10 years

L. Bergmeier, A. Senusi, F. Fortune, 2022, Frontiers in Medicine.

Clinical Management of Oral Mucosal Disease: A Literature Review

L. Bergmeier, F. Fortune, 2018 .